Exabis Library
Welcome to the e-CCO Library!
P143: Measuring the mediating effects of tofacitinib on health status in ulcerative colitis: data from the OCTAVE programme
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P143: Outcomes of ulcerative colitis-associated dysplasia patients treated with endoscopic submucosal dissection: An extended analysis of a single center cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P143: Quality in inflammatory bowel disease care: measure, educate, and improve—a real-life survey
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P143: Risk of impaired nutritional status is associated with an unfavourable disease outcome in IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P144 Vitamin C deficiency in inflammatory bowel disease: the forgotten micronutrient
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P144: Changes of fecal metabolic and lipidomic features by anti-tumor necrosis factor treatment and prediction of clinical remission in patients with ulcerative colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P144: Clock gene expression levels inversely correlate with disease activity in ulcerative colitis and Crohn’s disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P144: Comparison between faecal chitinase 3-like 1, matrix metalloprotease 9, and calprotectin to assess mucosal healing in Crohn’s disease: a multicentre prospective study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P144: Correlation between clinical, endoscopic, histological activity scores in a cohort of patients with ulcerative colitis: a prospective study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P144: Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P144: Protozoa and bacterial infections are relevant for clinical outcomes in ulcerative colitis: a study from Latin American country
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P144: TNF-inhibitor use and efficacy in upper-GI Crohn’s disease: results from a multicentre retrospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P145 Orofacial granulomatosis in Crohn’s disease: an ECCO CONFER multi-centre case series
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P145: Exploring mucosal function as a clinical endpoint in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P145: Inflammatory Bowel Disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVIBD-Surg)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P145: Measuring access and quality of care indicators in inflammatory bowel disease in a tertiary referral center
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P145: Migraine is the most frequent extra-intestinal manifestation in patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P145: Phenotypic progression of Crohn's disease : assessment of risk factors in a Tunisian population
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P145: Telephone straight-to-test (tSTT) improves early diagnosis of inflammatory bowel disease (IBD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P145: Ultrasonographic parameters associated with mucosal healing 1 year after infliximab therapy in Crohn’s Disease: a multicentric and prospective study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM